Submission Details
| 510(k) Number | K200060 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 13, 2020 |
| Decision Date | July 30, 2020 |
| Days to Decision | 199 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K200060 is an FDA 510(k) clearance for the Reprocessed NRG Transseptal Needle, a Septostomy Catheter, Reprocessed (Class II — Special Controls, product code QLZ), submitted by Innovative Health, LLC (Scottsdale, US). The FDA issued a Cleared decision on July 30, 2020, 199 days after receiving the submission on January 13, 2020. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.5175.
| 510(k) Number | K200060 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 13, 2020 |
| Decision Date | July 30, 2020 |
| Days to Decision | 199 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | QLZ — Septostomy Catheter, Reprocessed |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.5175 |
| Definition | To Create Or Enlarge An Atrial Septal Defect In The Heart. |